nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—CYP3A4—Temozolomide—melanoma	0.143	0.576	CbGbCtD
Methylergometrine—CYP3A4—Vemurafenib—melanoma	0.0784	0.316	CbGbCtD
Methylergometrine—CYP3A4—Docetaxel—melanoma	0.0269	0.108	CbGbCtD
Methylergometrine—Vasospasm—Carmustine—melanoma	0.0128	0.0853	CcSEcCtD
Methylergometrine—Cardiac disorder—Vemurafenib—melanoma	0.00385	0.0257	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Bleomycin—melanoma	0.00371	0.0247	CcSEcCtD
Methylergometrine—Thrombophlebitis—Carmustine—melanoma	0.00366	0.0244	CcSEcCtD
Methylergometrine—Thrombophlebitis—Temozolomide—melanoma	0.00354	0.0236	CcSEcCtD
Methylergometrine—Nasal congestion—Temozolomide—melanoma	0.00336	0.0224	CcSEcCtD
Methylergometrine—Anaphylactic shock—Vemurafenib—melanoma	0.00295	0.0197	CcSEcCtD
Methylergometrine—Nervous system disorder—Vemurafenib—melanoma	0.00289	0.0193	CcSEcCtD
Methylergometrine—Hypotension—Vemurafenib—melanoma	0.00275	0.0184	CcSEcCtD
Methylergometrine—Haematuria—Bleomycin—melanoma	0.00267	0.0178	CcSEcCtD
Methylergometrine—Sweating increased—Temozolomide—melanoma	0.00258	0.0172	CcSEcCtD
Methylergometrine—Thrombophlebitis—Docetaxel—melanoma	0.00235	0.0157	CcSEcCtD
Methylergometrine—Hallucination—Carmustine—melanoma	0.00218	0.0146	CcSEcCtD
Methylergometrine—Hallucination—Temozolomide—melanoma	0.00211	0.0141	CcSEcCtD
Methylergometrine—Diarrhoea—Vemurafenib—melanoma	0.00202	0.0135	CcSEcCtD
Methylergometrine—Tinnitus—Temozolomide—melanoma	0.00198	0.0132	CcSEcCtD
Methylergometrine—Cardiac disorder—Temozolomide—melanoma	0.00197	0.0131	CcSEcCtD
Methylergometrine—Dizziness—Vemurafenib—melanoma	0.00195	0.013	CcSEcCtD
Methylergometrine—Vomiting—Vemurafenib—melanoma	0.00187	0.0125	CcSEcCtD
Methylergometrine—Chest pain—Bleomycin—melanoma	0.00186	0.0124	CcSEcCtD
Methylergometrine—Rash—Vemurafenib—melanoma	0.00186	0.0124	CcSEcCtD
Methylergometrine—Dermatitis—Vemurafenib—melanoma	0.00186	0.0124	CcSEcCtD
Methylergometrine—Headache—Vemurafenib—melanoma	0.00185	0.0123	CcSEcCtD
Methylergometrine—Anaphylactic shock—Bleomycin—melanoma	0.00179	0.0119	CcSEcCtD
Methylergometrine—Nausea—Vemurafenib—melanoma	0.00175	0.0117	CcSEcCtD
Methylergometrine—Angina pectoris—Docetaxel—melanoma	0.00172	0.0114	CcSEcCtD
Methylergometrine—Hypotension—Bleomycin—melanoma	0.00167	0.0111	CcSEcCtD
Methylergometrine—Convulsion—Carmustine—melanoma	0.00165	0.011	CcSEcCtD
Methylergometrine—Hypertension—Carmustine—melanoma	0.00165	0.011	CcSEcCtD
Methylergometrine—Palpitations—Temozolomide—melanoma	0.00163	0.0109	CcSEcCtD
Methylergometrine—Chest pain—Carmustine—melanoma	0.00163	0.0108	CcSEcCtD
Methylergometrine—Paraesthesia—Bleomycin—melanoma	0.0016	0.0107	CcSEcCtD
Methylergometrine—Convulsion—Temozolomide—melanoma	0.0016	0.0107	CcSEcCtD
Methylergometrine—Hypertension—Temozolomide—melanoma	0.00159	0.0106	CcSEcCtD
Methylergometrine—Dyspnoea—Bleomycin—melanoma	0.00159	0.0106	CcSEcCtD
Methylergometrine—Tachycardia—Carmustine—melanoma	0.00152	0.0102	CcSEcCtD
Methylergometrine—Anaphylactic shock—Temozolomide—melanoma	0.00151	0.0101	CcSEcCtD
Methylergometrine—Nervous system disorder—Temozolomide—melanoma	0.00148	0.00986	CcSEcCtD
Methylergometrine—Hypotension—Carmustine—melanoma	0.00146	0.00972	CcSEcCtD
Methylergometrine—Hyperhidrosis—Temozolomide—melanoma	0.00146	0.00972	CcSEcCtD
Methylergometrine—Paraesthesia—Carmustine—melanoma	0.0014	0.00934	CcSEcCtD
Methylergometrine—Dyspnoea—Carmustine—melanoma	0.00139	0.00927	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Dactinomycin—melanoma	0.00136	0.00909	CcSEcCtD
Methylergometrine—Paraesthesia—Temozolomide—melanoma	0.00135	0.00902	CcSEcCtD
Methylergometrine—Dyspnoea—Temozolomide—melanoma	0.00134	0.00896	CcSEcCtD
Methylergometrine—Abdominal pain—Dactinomycin—melanoma	0.00132	0.00878	CcSEcCtD
Methylergometrine—Cardiac disorder—Docetaxel—melanoma	0.00131	0.00873	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Carmustine—melanoma	0.00127	0.0085	CcSEcCtD
Methylergometrine—Abdominal pain—Carmustine—melanoma	0.00123	0.00822	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Temozolomide—melanoma	0.00123	0.00822	CcSEcCtD
Methylergometrine—Abdominal pain—Temozolomide—melanoma	0.00119	0.00794	CcSEcCtD
Methylergometrine—Muscle spasms—Docetaxel—melanoma	0.00118	0.00787	CcSEcCtD
Methylergometrine—Diarrhoea—Dactinomycin—melanoma	0.00114	0.0076	CcSEcCtD
Methylergometrine—Vomiting—Bleomycin—melanoma	0.00114	0.00758	CcSEcCtD
Methylergometrine—Rash—Bleomycin—melanoma	0.00113	0.00751	CcSEcCtD
Methylergometrine—Dermatitis—Bleomycin—melanoma	0.00112	0.00751	CcSEcCtD
Methylergometrine—Palpitations—Docetaxel—melanoma	0.00108	0.00724	CcSEcCtD
Methylergometrine—Diarrhoea—Carmustine—melanoma	0.00107	0.00712	CcSEcCtD
Methylergometrine—Convulsion—Docetaxel—melanoma	0.00106	0.0071	CcSEcCtD
Methylergometrine—Nausea—Bleomycin—melanoma	0.00106	0.00708	CcSEcCtD
Methylergometrine—Hypertension—Docetaxel—melanoma	0.00106	0.00707	CcSEcCtD
Methylergometrine—Vomiting—Dactinomycin—melanoma	0.00106	0.00707	CcSEcCtD
Methylergometrine—Rash—Dactinomycin—melanoma	0.00105	0.00701	CcSEcCtD
Methylergometrine—Chest pain—Docetaxel—melanoma	0.00105	0.00697	CcSEcCtD
Methylergometrine—Dizziness—Carmustine—melanoma	0.00103	0.00688	CcSEcCtD
Methylergometrine—Diarrhoea—Temozolomide—melanoma	0.00103	0.00688	CcSEcCtD
Methylergometrine—Anaphylactic shock—Docetaxel—melanoma	0.001	0.00668	CcSEcCtD
Methylergometrine—Dizziness—Temozolomide—melanoma	0.000996	0.00665	CcSEcCtD
Methylergometrine—Vomiting—Carmustine—melanoma	0.000991	0.00661	CcSEcCtD
Methylergometrine—Nausea—Dactinomycin—melanoma	0.000989	0.0066	CcSEcCtD
Methylergometrine—Rash—Carmustine—melanoma	0.000983	0.00656	CcSEcCtD
Methylergometrine—Nervous system disorder—Docetaxel—melanoma	0.000982	0.00655	CcSEcCtD
Methylergometrine—Dermatitis—Carmustine—melanoma	0.000982	0.00655	CcSEcCtD
Methylergometrine—Tachycardia—Docetaxel—melanoma	0.000978	0.00652	CcSEcCtD
Methylergometrine—Headache—Carmustine—melanoma	0.000977	0.00652	CcSEcCtD
Methylergometrine—Vomiting—Temozolomide—melanoma	0.000958	0.00639	CcSEcCtD
Methylergometrine—Rash—Temozolomide—melanoma	0.00095	0.00634	CcSEcCtD
Methylergometrine—Dermatitis—Temozolomide—melanoma	0.000949	0.00633	CcSEcCtD
Methylergometrine—Headache—Temozolomide—melanoma	0.000944	0.0063	CcSEcCtD
Methylergometrine—Hypotension—Docetaxel—melanoma	0.000936	0.00625	CcSEcCtD
Methylergometrine—Nausea—Carmustine—melanoma	0.000926	0.00618	CcSEcCtD
Methylergometrine—Paraesthesia—Docetaxel—melanoma	0.0009	0.006	CcSEcCtD
Methylergometrine—Nausea—Temozolomide—melanoma	0.000895	0.00597	CcSEcCtD
Methylergometrine—Dyspnoea—Docetaxel—melanoma	0.000893	0.00596	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Docetaxel—melanoma	0.000819	0.00547	CcSEcCtD
Methylergometrine—Ergonovine—ABCB1—melanoma	0.000796	0.475	CrCbGaD
Methylergometrine—Abdominal pain—Docetaxel—melanoma	0.000792	0.00528	CcSEcCtD
Methylergometrine—Diarrhoea—Docetaxel—melanoma	0.000685	0.00457	CcSEcCtD
Methylergometrine—Dizziness—Docetaxel—melanoma	0.000662	0.00442	CcSEcCtD
Methylergometrine—Vomiting—Docetaxel—melanoma	0.000637	0.00425	CcSEcCtD
Methylergometrine—Rash—Docetaxel—melanoma	0.000632	0.00421	CcSEcCtD
Methylergometrine—Dermatitis—Docetaxel—melanoma	0.000631	0.00421	CcSEcCtD
Methylergometrine—Headache—Docetaxel—melanoma	0.000628	0.00419	CcSEcCtD
Methylergometrine—Nausea—Docetaxel—melanoma	0.000595	0.00397	CcSEcCtD
Methylergometrine—Ergotamine—ABCB1—melanoma	0.000448	0.267	CrCbGaD
Methylergometrine—Bromocriptine—ABCB1—melanoma	0.000432	0.258	CrCbGaD
Methylergometrine—HTR1E—Signaling Pathways—VEGFA—melanoma	6.63e-05	0.00011	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—MAPK3—melanoma	6.62e-05	0.00011	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TERT—melanoma	6.62e-05	0.00011	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RAC1—melanoma	6.6e-05	0.00011	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EDN1—melanoma	6.6e-05	0.00011	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—STAT3—melanoma	6.56e-05	0.000109	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NRAS—melanoma	6.55e-05	0.000109	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CD80—melanoma	6.53e-05	0.000109	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—APC—melanoma	6.52e-05	0.000109	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KIT—melanoma	6.52e-05	0.000109	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PIK3CG—melanoma	6.52e-05	0.000109	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—NRAS—melanoma	6.52e-05	0.000109	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—BRAF—melanoma	6.49e-05	0.000108	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MYC—melanoma	6.46e-05	0.000108	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGF1—melanoma	6.45e-05	0.000107	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CSF2—melanoma	6.45e-05	0.000107	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EGF—melanoma	6.44e-05	0.000107	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—IL2—melanoma	6.35e-05	0.000106	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HIF1A—melanoma	6.33e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IGF1—melanoma	6.33e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MAPK1—melanoma	6.32e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EGFR—melanoma	6.32e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—E2F1—melanoma	6.31e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—MAPK1—melanoma	6.3e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—EGFR—melanoma	6.3e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PIK3CB—melanoma	6.28e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MAPK3—melanoma	6.27e-05	0.000104	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PDGFRA—melanoma	6.24e-05	0.000104	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—MAPK3—melanoma	6.24e-05	0.000104	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ITGB3—melanoma	6.18e-05	0.000103	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PRKCA—melanoma	6.18e-05	0.000103	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—BRAF—melanoma	6.12e-05	0.000102	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MAP2K1—melanoma	6.11e-05	0.000102	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MYC—melanoma	6.1e-05	0.000102	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PIK3CD—melanoma	6.07e-05	0.000101	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SPP1—melanoma	6.06e-05	0.000101	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KDR—melanoma	6.05e-05	0.000101	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAP2K2—melanoma	6.04e-05	0.000101	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCL8—melanoma	6.03e-05	0.000101	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—PIK3CA—melanoma	6.02e-05	0.0001	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—KRAS—melanoma	5.97e-05	9.95e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IGF1—melanoma	5.97e-05	9.94e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MAPK1—melanoma	5.96e-05	9.94e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EGFR—melanoma	5.96e-05	9.94e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—KRAS—melanoma	5.95e-05	9.91e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—MAPK1—melanoma	5.94e-05	9.89e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—EGFR—melanoma	5.94e-05	9.89e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PLA2G6—melanoma	5.93e-05	9.87e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FN1—melanoma	5.82e-05	9.71e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGF2—melanoma	5.82e-05	9.69e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL2—melanoma	5.77e-05	9.61e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAP2K1—melanoma	5.77e-05	9.61e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TERT—melanoma	5.75e-05	9.57e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RAC1—melanoma	5.73e-05	9.55e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PIK3CD—melanoma	5.73e-05	9.55e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NOTCH1—melanoma	5.7e-05	9.5e-05	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—PIK3CA—melanoma	5.67e-05	9.46e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—KRAS—melanoma	5.63e-05	9.39e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—KRAS—melanoma	5.61e-05	9.35e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CD80—melanoma	5.58e-05	9.31e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KIT—melanoma	5.57e-05	9.29e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PIK3CG—melanoma	5.57e-05	9.29e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APC—melanoma	5.57e-05	9.29e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—NRAS—melanoma	5.57e-05	9.29e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EGF—melanoma	5.51e-05	9.18e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HIF1A—melanoma	5.49e-05	9.16e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PIK3CA—melanoma	5.49e-05	9.14e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGF2—melanoma	5.48e-05	9.14e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—PIK3CA—melanoma	5.46e-05	9.1e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MDM2—melanoma	5.44e-05	9.07e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ERBB2—melanoma	5.36e-05	8.94e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—MAPK3—melanoma	5.34e-05	8.9e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—VCAN—melanoma	5.32e-05	8.87e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TP53—melanoma	5.31e-05	8.85e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PIK3CB—melanoma	5.29e-05	8.82e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KDR—melanoma	5.25e-05	8.76e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—BRAF—melanoma	5.24e-05	8.73e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PIK3CA—melanoma	5.18e-05	8.63e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—PIK3CA—melanoma	5.15e-05	8.59e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MDM2—melanoma	5.13e-05	8.55e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IGF1—melanoma	5.1e-05	8.51e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCL8—melanoma	5.09e-05	8.48e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—MAPK1—melanoma	5.08e-05	8.47e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—EGFR—melanoma	5.08e-05	8.46e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HRAS—melanoma	5.08e-05	8.46e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ERBB2—melanoma	5.06e-05	8.43e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FN1—melanoma	5.06e-05	8.43e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—HRAS—melanoma	5.05e-05	8.42e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TP53—melanoma	5.01e-05	8.34e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PIK3CB—melanoma	4.99e-05	8.32e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CDKN1B—melanoma	4.97e-05	8.28e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOTCH1—melanoma	4.95e-05	8.25e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAP2K1—melanoma	4.93e-05	8.22e-05	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AKT1—melanoma	4.91e-05	8.19e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PIK3CD—melanoma	4.9e-05	8.17e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CASP3—melanoma	4.87e-05	8.12e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL2—melanoma	4.86e-05	8.1e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6—melanoma	4.86e-05	8.1e-05	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—PIK3CA—melanoma	4.85e-05	8.09e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CD80—melanoma	4.85e-05	8.08e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PIK3CG—melanoma	4.84e-05	8.07e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APC—melanoma	4.84e-05	8.07e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KIT—melanoma	4.84e-05	8.07e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—NRAS—melanoma	4.84e-05	8.07e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6—melanoma	4.84e-05	8.06e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCL8—melanoma	4.8e-05	8e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—KRAS—melanoma	4.8e-05	8e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HRAS—melanoma	4.79e-05	7.98e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EGF—melanoma	4.78e-05	7.97e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—HRAS—melanoma	4.77e-05	7.94e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCND1—melanoma	4.74e-05	7.9e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CTNNB1—melanoma	4.69e-05	7.82e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGF2—melanoma	4.69e-05	7.82e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CDKN1B—melanoma	4.69e-05	7.81e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—MAPK3—melanoma	4.64e-05	7.73e-05	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AKT1—melanoma	4.63e-05	7.72e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MMP9—melanoma	4.6e-05	7.67e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CASP3—melanoma	4.59e-05	7.65e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL2—melanoma	4.59e-05	7.64e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CDKN1A—melanoma	4.59e-05	7.64e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6—melanoma	4.58e-05	7.64e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PTEN—melanoma	4.57e-05	7.62e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6—melanoma	4.56e-05	7.6e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NFKB1—melanoma	4.55e-05	7.59e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—BRAF—melanoma	4.55e-05	7.58e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP17A1—melanoma	4.49e-05	7.48e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AKT1—melanoma	4.48e-05	7.47e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCND1—melanoma	4.47e-05	7.45e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AKT1—melanoma	4.46e-05	7.44e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IGF1—melanoma	4.43e-05	7.39e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CTNNB1—melanoma	4.43e-05	7.38e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—MAPK1—melanoma	4.41e-05	7.35e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—EGFR—melanoma	4.41e-05	7.35e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PIK3CA—melanoma	4.41e-05	7.35e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MDM2—melanoma	4.39e-05	7.32e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MMP9—melanoma	4.34e-05	7.23e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ERBB2—melanoma	4.33e-05	7.21e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CDKN1A—melanoma	4.32e-05	7.21e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PTEN—melanoma	4.31e-05	7.19e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NFKB1—melanoma	4.29e-05	7.16e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAP2K1—melanoma	4.28e-05	7.14e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PIK3CB—melanoma	4.27e-05	7.12e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PIK3CD—melanoma	4.26e-05	7.09e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GNA11—melanoma	4.24e-05	7.07e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AKT1—melanoma	4.23e-05	7.05e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PIK3CA—melanoma	4.21e-05	7.02e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AKT1—melanoma	4.21e-05	7.01e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—KRAS—melanoma	4.17e-05	6.94e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—FASN—melanoma	4.15e-05	6.92e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—VEGFA—melanoma	4.13e-05	6.89e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL8—melanoma	4.1e-05	6.84e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—STAT3—melanoma	4.09e-05	6.82e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SLC5A5—melanoma	4.08e-05	6.8e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NRAS—melanoma	4.08e-05	6.8e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—HRAS—melanoma	4.08e-05	6.8e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGF2—melanoma	4.07e-05	6.79e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CDKN1B—melanoma	4.01e-05	6.68e-05	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AKT1—melanoma	3.97e-05	6.61e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GNAQ—melanoma	3.94e-05	6.57e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CD44—melanoma	3.94e-05	6.57e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CASP3—melanoma	3.93e-05	6.55e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL2—melanoma	3.92e-05	6.54e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MAPK3—melanoma	3.91e-05	6.51e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6—melanoma	3.9e-05	6.5e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—VEGFA—melanoma	3.9e-05	6.49e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—STAT3—melanoma	3.86e-05	6.43e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NRAS—melanoma	3.85e-05	6.41e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PIK3CA—melanoma	3.83e-05	6.38e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCND1—melanoma	3.82e-05	6.37e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MDM2—melanoma	3.81e-05	6.35e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MYC—melanoma	3.8e-05	6.34e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CTNNB1—melanoma	3.79e-05	6.31e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP1B1—melanoma	3.78e-05	6.3e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ERBB2—melanoma	3.76e-05	6.26e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MAPK1—melanoma	3.72e-05	6.2e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EGFR—melanoma	3.72e-05	6.2e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MMP9—melanoma	3.71e-05	6.19e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PIK3CB—melanoma	3.71e-05	6.18e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CDKN1A—melanoma	3.7e-05	6.16e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTEN—melanoma	3.69e-05	6.15e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAPK3—melanoma	3.69e-05	6.14e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NFKB1—melanoma	3.67e-05	6.12e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AKT1—melanoma	3.6e-05	6e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MYC—melanoma	3.59e-05	5.98e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL8—melanoma	3.56e-05	5.94e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—HRAS—melanoma	3.54e-05	5.9e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—KRAS—melanoma	3.51e-05	5.85e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAPK1—melanoma	3.51e-05	5.85e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EGFR—melanoma	3.51e-05	5.84e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CDKN1B—melanoma	3.48e-05	5.8e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AKT1—melanoma	3.44e-05	5.74e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CASP3—melanoma	3.41e-05	5.69e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL2—melanoma	3.41e-05	5.68e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6—melanoma	3.39e-05	5.65e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—VEGFA—melanoma	3.33e-05	5.56e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCND1—melanoma	3.32e-05	5.53e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KRAS—melanoma	3.31e-05	5.52e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—STAT3—melanoma	3.3e-05	5.5e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NRAS—melanoma	3.29e-05	5.49e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CTNNB1—melanoma	3.29e-05	5.48e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PIK3CA—melanoma	3.23e-05	5.38e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP9—melanoma	3.22e-05	5.37e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CDKN1A—melanoma	3.21e-05	5.35e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTEN—melanoma	3.21e-05	5.34e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NFKB1—melanoma	3.19e-05	5.32e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAPK3—melanoma	3.15e-05	5.26e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AKT1—melanoma	3.13e-05	5.21e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TP53—melanoma	3.12e-05	5.2e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ABCB1—melanoma	3.11e-05	5.19e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MYC—melanoma	3.07e-05	5.11e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PIK3CA—melanoma	3.04e-05	5.07e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAPK1—melanoma	3e-05	5e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EGFR—melanoma	3e-05	5e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HRAS—melanoma	2.99e-05	4.98e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TP53—melanoma	2.94e-05	4.91e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—VEGFA—melanoma	2.89e-05	4.82e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—STAT3—melanoma	2.87e-05	4.78e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PRKCA—melanoma	2.86e-05	4.77e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NRAS—melanoma	2.86e-05	4.77e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6—melanoma	2.86e-05	4.76e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ERCC2—melanoma	2.84e-05	4.73e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KRAS—melanoma	2.83e-05	4.72e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HRAS—melanoma	2.82e-05	4.69e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAPK3—melanoma	2.74e-05	4.56e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6—melanoma	2.7e-05	4.49e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MYC—melanoma	2.66e-05	4.44e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AKT1—melanoma	2.64e-05	4.39e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAPK1—melanoma	2.61e-05	4.34e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EGFR—melanoma	2.61e-05	4.34e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PIK3CA—melanoma	2.6e-05	4.34e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TP53—melanoma	2.52e-05	4.2e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKT1—melanoma	2.49e-05	4.14e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KRAS—melanoma	2.46e-05	4.1e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HRAS—melanoma	2.41e-05	4.01e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6—melanoma	2.31e-05	3.84e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.26e-05	3.77e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3CG—melanoma	2.24e-05	3.74e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TP53—melanoma	2.19e-05	3.65e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPARG—melanoma	2.17e-05	3.61e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKT1—melanoma	2.13e-05	3.54e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HRAS—melanoma	2.09e-05	3.49e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6—melanoma	2e-05	3.34e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3CD—melanoma	1.97e-05	3.29e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALB—melanoma	1.95e-05	3.25e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKT1—melanoma	1.85e-05	3.08e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3CB—melanoma	1.72e-05	2.87e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS2—melanoma	1.7e-05	2.84e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTEN—melanoma	1.49e-05	2.48e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3CA—melanoma	1.05e-05	1.75e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AKT1—melanoma	8.56e-06	1.43e-05	CbGpPWpGaD
